Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Smith & Nephew buys Rotation Medical for US$125mln

Smith & Nephew will pay US$125mln for Rotation Medical plus up to a further US$85mln over the next five years, contingent on financial performance
shoulder
Rotation’s rotator cuff technology complements Smith & Nephew's shoulder repair technologies

Medical equipment group Smith & Nephew (LON:SN.) has completed the acquisition of Rotation Medical Inc., a US-based developer of tissue-regeneration technology to treat rotator-cuff disease.

Smith & Nephew is to pay US$125mln for Rotation plus up to a further US$85mln over the next five years, contingent on financial performance.

READ: Smith & Nephew says full year growth to be at lower end of guidance range

The company said Rotation’s rotator cuff system is “highly complementary” to its existing portfolio of shoulder repair technologies to supplement repairs of more complex tears.

The procedure involves using a bioinductive implant that helps tendons heal by inducing growth of new tendon-like tissue, enhancing the body’s natural healing response.

It helps prevent tear progression and reduce the incidence of re-tears. 

READ: Smith & Nephew chief executive Olivier Bohuon to step down next year

Smith&Nephew said there are more than 650,000 rotator cuff procedures per year in the US growing at a rate of 5-6% per annum.  The cuff system will be sold through Smith & Nephew's larger sports medicine sales force and the integrated Rotation Medical sales team. 

View full SN. profile View Profile

Smith & Nephew PLC Timeline

Related Articles

Skin beauty
Thu
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
leg bones
March 31 2018
"We are now in the position of really trying to kick on in 2018"
Zelda's Stewart Washer at Proactive's CEO Sessions
November 17 2017
Stewart Washer at Proactive's CEO Sessions this week.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use